Research & Development

伊人成人综合伊人成综合人网伊人222综合网图片拉夏贝尔现资金危局 实控人质押近乎全部爆仓


  “過來!”   “聲音再大點,再引誘一些人出來。”伊人成人综合   彭琪撇撇嘴吧道︰“師傅偏心,當年為了教導你,給了你一箱子黃金任由你揮霍。等到我們出來的時候,問師傅要這樣的福利,師傅除過說了一個‘滾’字之外,再無其他。我哪里有錢去青樓?”伊人成综合人网   千萬別弄成一團糟啊。   這個過程本該是狠辣無情的……伊人222综合网图片   人人都很忙碌,雲瑯自己卻清閑無比。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo